MedTrace Logo

Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

NCT05287633 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-02-25

No results posted yet for this study

Summary

evaluate the interest of proton pump inhibitors in subjects with or with GI symptoms who intend to observe fasting in Ramadan. The investigators will compare the effectiveness of proton pump inhibitors to prevent or reduce the signs of dyspepsia during Ramadan compared to placebo.

Conditions

  • Dyspepsia

Interventions

DRUG

Esomeprazole

Patients are given a box of capsules of which they take 1capsule/day during the month of ramadan

DRUG

Placebo

Patients are given a box of capsules of which they take 1capsule/day during the month of ramadan

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • Semir Nouira, Professor · University of Monastir

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-20
Primary Completion
2020-12-15
Completion
2024-12-30

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05287633 on ClinicalTrials.gov